Deuruxolitinib: Safety Study in Healthy Adults

We are testing a new medication to see how safe it is and how the body reacts to it in healthy adults. This study helps us understand its potential for future treatments.

6-12 monthsSafety phase (I)AllergologyInfectious DiseasesRheumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Terapia S.A.
CPP Department
Cluj-Napoca, Romania
Sponsor: Sun Pharmaceutical Industries Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.